ConvaTec Group PLC Director/PDMR Shareholding (9598W)

TIDMCTEC

RNS Number : 9598W

ConvaTec Group PLC

06 August 2018

6 August 2018

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified that Mr Frank Schulkes, the Company's Chief Financial Officer and a person discharging managerial responsibility ( PDMR ), has subscribed to the ConvaTec Group Plc Save As You Earn Scheme (the SAYE Scheme ). On 16 July 2018, 9,782 options over ordinary shares of 10 pence each in the share capital of the Company ( Shares ) were granted to Mr Schulkes, subject to a time vesting period of three years.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
  1      Details of the person discharging managerial responsibilities/person 
          closely associated 
  a)    Name                                           Mr Frank Schulkes 
  2     Reason for the notification 
  a)    Position/Status                               Chief Financial Officer 
  b)    Initial notification/Amendment                 Initial notification 
  3     Details of the issuer, emission allowance market participant, 
         auction platform, auctioneer or auction monitor 
  a)    Name                                           ConvaTec Group Plc 
  b)    LEI                                            213800LS272L4FIDOH92 
  4     Details of the transaction(s): section to be repeated for 
         (i) each type of instrument; (ii) each type of transaction; 
         (iii) each date; and (iv) each place where transactions have 
         been conducted 
  a)    Description of the financial                   Ordinary shares of 10p each in ConvaTec Group Plc ("Shares") 
         instrument, type of instrument 
         Identification code                            GB00BD3VFW73 
  b)    Nature of the transaction                     Grant of options under the SAYE Scheme 
  c)    Price(s) and volume(s)                         Exercise price(s)                             Volume granted: 
                                                        GBP1.84                                      9,782 
  d)    Aggregated information 
         - Aggregated volume                             9,782 
         - Price                                         GBP17,998.88 
  e)    Date of the transaction                        2018-07-16 
  f)    Place of the transaction                       Outside a trading venue 
 
 

Enquiries

Media

   Bobby Leach, VP Group Corporate Affairs, ConvaTec                        [phone] 

Alastair Elwen, Finsbury [phone]

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec [phone]

   Kirsty Law, Director Investor Relations, ConvaTec                              [phone] 

[e-mail]

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHLLFVVTSIRIIT

(END) Dow Jones Newswires

August 06, 2018 09:36 ET (13:36 GMT)